Hyperbaric oxygen suppresses HIV replication

This was a laboratory-based “in vitro” study which showed that hyperbaric exposure was able to suppress HIV-1 replication.

“The exposure to hyperbaric oxygen at the pressure of 2.4 ATA and 98% oxygen was able to produce ROS and RNS molecules, which play a role in cellular adaptive responses through increasing the expression of nfĸb, p21 and mRNA of interferon α2 plays a role in inhibition mechanism of HIV-1 replication in cells.” <view study>

Hyperbaric therapy reduced long COVID related fatigue in just 10 sessions

Long COVID-related fatigue can be debilitating, and may affect young people who were previously in economic employment. All patients had been suffering from long COVID symptoms for over 3 months. The results presented here suggest potential benefits of HBOT, with statistically significant results following 10 sessions of HBOT at 2.4 ATA <view study>